PhRMA Proposes New Compendia To Guide Off-Label Rx Coverage
Executive Summary
CMS should expand its list of drug compendia that can support coverage of off-label drug use, the Pharmaceutical Research & Manufacturers of America said in comments on a proposal to cover four cancer drugs used in clinical trials
You may also be interested in...
Drug Manufacturers Face Public Opinion Challenge In Medicare Rx
Pharmaceutical manufacturers face a significant challenge in countering bad publicity about the Medicare prescription drug program, National Pharmaceutical Council President Karen Williams said at a World Congress Leadership Summit on Medicare May 23 in Washington, D.C
Drug Manufacturers Face Public Opinion Challenge In Medicare Rx
Pharmaceutical manufacturers face a significant challenge in countering bad publicity about the Medicare prescription drug program, National Pharmaceutical Council President Karen Williams said at a World Congress Leadership Summit on Medicare May 23 in Washington, D.C
CMS Proposes Broad Criteria For Linking Reimbursement To Data Collection
The Centers for Medicare & Medicaid Services is proposing a broad range of circumstances under which the agency could make data collection a condition for Medicare coverage of certain products and services